BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Xcopri (Cenobamate) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Xcopri (Cenobamate)\, from ClinicalTrials
 .gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06590896-8851@assetmemo.bio
DTSTAMP:20261121T005714Z
DTSTART;VALUE=DATE:20270131
DTEND;VALUE=DATE:20270201
SUMMARY:Xcopri (Cenobamate): Phase 2 readout est. (NCT06590896)
DESCRIPTION:Xcopri (Cenobamate)\, phase 2\, Epilepsy.\nStudy: Safety of Cen
 obamate in Japanese Subjects With Partial Onset Seizures\nEstimated primar
 y completion: 31 January 2027. This is a ClinicalTrials.gov estimate\, not
  a confirmed readout date\, and it can move.\nDrug page: https://assetmemo
 .bio/drug/cenobamate#upcoming-events\nRegistry record: https://clinicaltri
 als.gov/study/NCT06590896
URL:https://assetmemo.bio/drug/cenobamate#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06579573-8851@assetmemo.bio
DTSTAMP:20261121T005714Z
DTSTART;VALUE=DATE:20270131
DTEND;VALUE=DATE:20270201
SUMMARY:Xcopri (Cenobamate): Phase 3 readout est. (NCT06579573)
DESCRIPTION:Xcopri (Cenobamate)\, phase 3\, Epilepsy.\nStudy: ONO-2017 Stud
 y Japanese Patients With Primary Generalized Tonic Clonic Seizures.\nEstim
 ated primary completion: 31 January 2027. This is a ClinicalTrials.gov est
 imate\, not a confirmed readout date\, and it can move.\nDrug page: https:
 //assetmemo.bio/drug/cenobamate#upcoming-events\nRegistry record: https://
 clinicaltrials.gov/study/NCT06579573
URL:https://assetmemo.bio/drug/cenobamate#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06453213-8851@assetmemo.bio
DTSTAMP:20261121T005714Z
DTSTART;VALUE=DATE:20270526
DTEND;VALUE=DATE:20270527
SUMMARY:Xcopri (Cenobamate): Phase 4 readout est. (NCT06453213)
DESCRIPTION:Xcopri (Cenobamate)\, phase 4\, Epilepsy.\nStudy: Open-label St
 udy of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Re
 current Partial-Onset Epilepsy\nEstimated primary completion: 26 May 2027.
  This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, an
 d it can move.\nDrug page: https://assetmemo.bio/drug/cenobamate#upcoming-
 events\nRegistry record: https://clinicaltrials.gov/study/NCT06453213
URL:https://assetmemo.bio/drug/cenobamate#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07594158-8851@assetmemo.bio
DTSTAMP:20261121T005714Z
DTSTART;VALUE=DATE:20280330
DTEND;VALUE=DATE:20280331
SUMMARY:Xcopri (Cenobamate): Phase 3 readout est. (NCT07594158)
DESCRIPTION:Xcopri (Cenobamate)\, phase 3\, Epilepsy.\nStudy: A Study to Ev
 aluate the Safety\, Efficacy\, and PK of ONO-2017 in Japanese Patients Wit
 h POS 2 to 17 Year Olds\nEstimated primary completion: 30 March 2028. This
  is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it 
 can move.\nDrug page: https://assetmemo.bio/drug/cenobamate#upcoming-event
 s\nRegistry record: https://clinicaltrials.gov/study/NCT07594158
URL:https://assetmemo.bio/drug/cenobamate#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06352723-8851@assetmemo.bio
DTSTAMP:20261121T005714Z
DTSTART;VALUE=DATE:20280630
DTEND;VALUE=DATE:20280701
SUMMARY:Xcopri (Cenobamate): Phase 1 readout est. (NCT06352723)
DESCRIPTION:Xcopri (Cenobamate)\, phase 1\, Epilepsy.\nStudy: Cenobamate in
  the Intensive Care Unit\nEstimated primary completion: June 2028. This is
  a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can
  move.\nDrug page: https://assetmemo.bio/drug/cenobamate#upcoming-events\n
 Registry record: https://clinicaltrials.gov/study/NCT06352723
URL:https://assetmemo.bio/drug/cenobamate#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
